dr. tripathy on decision-making for sequencing therapies for her2-positive mbc
Published 10 years ago • 117 plays • Length 1:20Download video MP4
Download video MP3
Similar videos
-
0:54
dr. tripathy on the treatment of patients with metastatic breast cancer
-
1:06
dr. tripathy on determining the best her2 targeted therapy
-
2:00
dr. tripathy on personalized therapy options in metastatic breast cancer
-
7:40
sequencing of therapy in r/r her2 mbc
-
1:10
dr. tripathy on targeting her2 in breast cancer
-
1:43
dr. tripathy discusses her2 targeted therapies
-
1:28
dr. tripathy on immunotherapy potential in her2-positive breast cancer
-
1:08
dr. tripathy on standard and emerging treatment advances for her2 breast cancer
-
3:27
dr. tripathy on neoadjuvant treatment strategies in her2 breast cancer
-
1:13
dr. chagpar on sequencing therapies for her2-positive breast cancer
-
2:24
dr. tripathy on genomically guided therapy in breast cancer
-
1:12
dr. tripathy discusses breast cancer biomarkers
-
1:44
dr. tripathy on the evolving treatment landscape of her2 breast cancer
-
0:51
dr. tripathy discusses immunotherapy in her2 breast cancer
-
1:09
dr. tripathy on trastuzumab deruxtecan versus t-dm1 in her2-expressing breast cancers
-
2:13
dr. tripathy on frontline endocrine therapies in hr breast cancer
-
6:57
practical advice on treating her2 metastatic breast cancer
-
0:38
dr. tripathy on completing new assays after recurrence
-
2:14
dr. pegram on sequencing therapies in her2-positive breast cancer